Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Disanto

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
BMC Medicine|July 16, 2013
Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune diseaseAdam E Handel, Geir K Sandve, Giulio Disanto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2013
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohortCaren Ramien, Annette Pachnio, Sofia Sisay, et al.
Annals of Neurology|May 18, 2017
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisGiulio Disanto, Christian Barro, Pascal Benkert, et al.
NPJ Parkinson'S Disease|December 21, 2021
Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's diseaseElena Vacchi, Camilla Senese, Giacomo Chiaro, et al.
Brain : a Journal of Neurology|April 29, 2022
Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathiesElena Vacchi, Edoardo Lazzarini, Sandra Pinton, et al.
Annals of Neurology|May 10, 2018
Prodromal symptoms of multiple sclerosis in primary careGiulio Disanto, Chiara Zecca, Sharon MacLachlan, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2015
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndromeGiulio Disanto, Rocco Adiutori, Ruth Dobson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2016
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severityJens Kuhle, Christian Barro, Giulio Disanto, et al.
Brain : a Journal of Neurology|June 4, 2018
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosisChristian Barro, Pascal Benkert, Giulio Disanto, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
BMC Medicine|July 16, 2013
Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune diseaseAdam E Handel, Geir K Sandve, Giulio Disanto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2013
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohortCaren Ramien, Annette Pachnio, Sofia Sisay, et al.
Annals of Neurology|May 18, 2017
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisGiulio Disanto, Christian Barro, Pascal Benkert, et al.
NPJ Parkinson'S Disease|December 21, 2021
Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's diseaseElena Vacchi, Camilla Senese, Giacomo Chiaro, et al.
Brain : a Journal of Neurology|April 29, 2022
Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathiesElena Vacchi, Edoardo Lazzarini, Sandra Pinton, et al.
Annals of Neurology|May 10, 2018
Prodromal symptoms of multiple sclerosis in primary careGiulio Disanto, Chiara Zecca, Sharon MacLachlan, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2015
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndromeGiulio Disanto, Rocco Adiutori, Ruth Dobson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2016
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severityJens Kuhle, Christian Barro, Giulio Disanto, et al.
Brain : a Journal of Neurology|June 4, 2018
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosisChristian Barro, Pascal Benkert, Giulio Disanto, et al.
Pageof 13